Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles V Pollack

Showing results (111-120 of 232) with videos related to

Pageof 24
Sort By:
Annals of Surgery|October 11, 2019
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD StudyJerrold H Levy, Joanne van Ryn, Frank W Sellke, et al.
The American Journal of Emergency Medicine|September 18, 2009
Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussionJames Hoekstra, Marc Cohen, Robert Giugliano, et al.
American Heart Journal|October 27, 2009
Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiativeEzra A Amsterdam, Eric D Peterson, Fang-Shu Ou, et al.
Pharmacotherapy|May 30, 2009
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiativeSarah A Spinler, Fang-Shu Ou, Matthew T Roe, et al.
Archives of Internal Medicine|July 27, 2005
Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarctionMatthew T Roe, Lori S Parsons, Charles V Pollack, et al.
The American Journal of Emergency Medicine|September 21, 2014
Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?Charles V Pollack, Jerrold H Levy, John Eikelboom, et al.
ESC Heart Failure|December 11, 2024
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episodeCharles V Pollack, David Arroyo, Eiichiro Kanda, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
Annals of Emergency Medicine|December 2, 2004
Is the initial diagnostic impression of "noncardiac chest pain" adequate to exclude cardiac disease?Chadwick D Miller, Christopher J Lindsell, Sorabh Khandelwal, et al.
Circulation|January 13, 2006
Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysisBrahmajee K Nallamothu, Yongfei Wang, David J Magid, et al.
Pageof 24

Showing results (111-120 of 232) with videos related to

Sort By:
Pageof 24
Annals of Surgery|October 11, 2019
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD StudyJerrold H Levy, Joanne van Ryn, Frank W Sellke, et al.
The American Journal of Emergency Medicine|September 18, 2009
Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussionJames Hoekstra, Marc Cohen, Robert Giugliano, et al.
American Heart Journal|October 27, 2009
Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiativeEzra A Amsterdam, Eric D Peterson, Fang-Shu Ou, et al.
Pharmacotherapy|May 30, 2009
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiativeSarah A Spinler, Fang-Shu Ou, Matthew T Roe, et al.
Archives of Internal Medicine|July 27, 2005
Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarctionMatthew T Roe, Lori S Parsons, Charles V Pollack, et al.
The American Journal of Emergency Medicine|September 21, 2014
Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?Charles V Pollack, Jerrold H Levy, John Eikelboom, et al.
ESC Heart Failure|December 11, 2024
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episodeCharles V Pollack, David Arroyo, Eiichiro Kanda, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
Annals of Emergency Medicine|December 2, 2004
Is the initial diagnostic impression of "noncardiac chest pain" adequate to exclude cardiac disease?Chadwick D Miller, Christopher J Lindsell, Sorabh Khandelwal, et al.
Circulation|January 13, 2006
Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysisBrahmajee K Nallamothu, Yongfei Wang, David J Magid, et al.
Pageof 24